Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$123,692,036
-$154,830,356 QoQ
Shares Held
2,127,852
-55.6% QoQ
Ownership
1.43%
of shares outstanding
% of Portfolio
2.68%
of 13F equity value
Holder Rank
#16
of 329 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Derivatives in PCVX
reported options exposure · as of Sep 30, 2024CallValue
$31,629,936
CallShares
276,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Paradigm Biocapital Advisors LP holds $4,608,890,546 across 28 Biotechnology names. PCVX ranks #14 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
6,361,323 | $1,191,348,571 | |
| 2 | EWTX |
Edgewise Therapeutics, Inc.
|
10,215,455 | $415,053,936 | |
| 3 | GMAB |
Genmab A/S
|
13,133,131 | $360,767,108 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
3,840,778 | $340,984,270 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
1,576,385 | $209,233,581 | |
| 6 | ORKA |
Oruka Therapeutics, Inc.
|
2,144,526 | $204,094,539 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
6,357,523 | $198,736,168 | |
| 8 | BLTE |
Belite Bio, Inc
|
1,232,877 | $189,844,564 |
All Filings in PCVX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123,692,036 | 2,127,852 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $278,522,392 | 4,793,020 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $187,698,442 | 4,068,020 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $136,326,875 | 3,784,755 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $109,650,930 | 3,372,837 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $64,059,122 | 1,696,481 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $116,469,343 | 1,422,787 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $71,730,935 | 627,732 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $31,629,936 | 276,800 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $47,360,023 | 627,202 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $84,704,058 | 1,239,995 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||